Anthera Pharmaceuticals (ANTH) To Offer Common Shares
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Join SI Premium – FREE
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) intends to offer and sell shares of its common stock in an underwritten public offering.
The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any. Citi and Leerink Swann LLC are acting as joint book-running managers in the offering and Canaccord Genuity Inc. is acting as lead co-manager in the offering.
The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any. Citi and Leerink Swann LLC are acting as joint book-running managers in the offering and Canaccord Genuity Inc. is acting as lead co-manager in the offering.
Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Citi, Genuity Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
